Skip to content

Characteristics and prognostic outcomes of diaphragmatic ultrasound in myasthenia gravis

Characteristics and prognostic outcomes of diaphragmatic ultrasound in myasthenia gravis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104395
Enrollment
Unknown
Registered
2025-06-17
Start date
2024-07-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myasthenia gravis

Interventions

myasthenia gravis group:NA
control group:NA

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients who seek treatment at the First Affiliated Hospital of Chongqing Medical University and have fluctuating skeletal muscle weakness and at least one of the following three conditions will be included: Positive response to cholinesterase inhibitors; repetitive electrical stimulation shows decreasing frequency and positive AChR or muscle-specific kinase (MuSK) antibodies;

Exclusion criteria

Exclusion criteria: 1.Patients with lung disease or heart failure, or a history of non-invasive ventilator or tracheotomy;

Design outcomes

Primary

MeasureTime frame
Diaphragm thickness;

Secondary

MeasureTime frame
QMG;dose of immunosuppressants;Respiratory infection occurred within 6 months;Diaphragmatic excursion;Diaphragmatic elasticity;blood gas analyses;Complete Blood Count;

Countries

China

Contacts

Public ContactFei Xiao

The First Affiliated Hospital of Chongqing Medical University

feixiao81@126.com+86 23 89011876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026